These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 35352855)

  • 21. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
    Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
    Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium.
    Grover M; Bernard CE; Pasricha PJ; Lurken MS; Faussone-Pellegrini MS; Smyrk TC; Parkman HP; Abell TL; Snape WJ; Hasler WL; McCallum RW; Nguyen L; Koch KL; Calles J; Lee L; Tonascia J; Ünalp-Arida A; Hamilton FA; Farrugia G;
    Neurogastroenterol Motil; 2012 Jun; 24(6):531-9, e249. PubMed ID: 22339929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective Study.
    Ghosh N; Emond B; Lafeuille MH; Côté-Sergent A; Lefebvre P; Huang Q
    Clin Ther; 2021 Aug; 43(8):1285-1299. PubMed ID: 34332789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and Diagnosis of Gastroparesis in the United States: A Population-based Study.
    Syed AR; Wolfe MM; Calles-Escandon J
    J Clin Gastroenterol; 2020 Jan; 54(1):50-54. PubMed ID: 31135630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary.
    Fehnel S; Fiedorek FT; Nelson L; DiBenedetti D; Spence S; Carson RT
    Clin Exp Gastroenterol; 2019; 12():93-103. PubMed ID: 30863134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment.
    Kim BJ; Kuo B
    J Neurogastroenterol Motil; 2019 Jan; 25(1):27-35. PubMed ID: 30509017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis.
    Parkman HP; Yamada G; Van Natta ML; Yates K; Hasler WL; Sarosiek I; Grover M; Schey R; Abell TL; Koch KL; Kuo B; Clarke J; Farrugia G; Nguyen L; Snape WJ; Miriel L; Tonascia J; Hamilton F; Pasricha PJ; McCallum RW
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1489-1499.e8. PubMed ID: 30404035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroparesis.
    Camilleri M; Chedid V; Ford AC; Haruma K; Horowitz M; Jones KL; Low PA; Park SY; Parkman HP; Stanghellini V
    Nat Rev Dis Primers; 2018 Nov; 4(1):41. PubMed ID: 30385743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors.
    Nassar Y; Richter S
    Gastroenterology Res; 2018 Oct; 11(5):340-345. PubMed ID: 30344804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of hospital readmission and care fragmentation in gastroparesis: A nationwide analysis.
    Qayed E; Muftah M
    World J Gastrointest Endosc; 2018 Sep; 10(9):200-209. PubMed ID: 30283603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Gastroparesis: Principles and Current Trends in Management.
    Krishnasamy S; Abell TL
    Diabetes Ther; 2018 Jul; 9(Suppl 1):1-42. PubMed ID: 29934758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Critical Review of the Current Clinical Landscape of Gastroparesis.
    Fosso CL; Quigley EMM
    Gastroenterol Hepatol (N Y); 2018 Mar; 14(3):140-145. PubMed ID: 29928159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013.
    Hirsch W; Nee J; Ballou S; Petersen T; Friedlander D; Lee HN; Cheng V; Lembo A
    J Clin Gastroenterol; 2019 Feb; 53(2):109-113. PubMed ID: 29256990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews.
    Ervin CM; Reasner DS; Hanlon JT; Fehnel SE
    Adv Ther; 2017 Dec; 34(12):2680-2692. PubMed ID: 29079987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare utilization and costs associated with gastroparesis.
    Wadhwa V; Mehta D; Jobanputra Y; Lopez R; Thota PN; Sanaka MR
    World J Gastroenterol; 2017 Jun; 23(24):4428-4436. PubMed ID: 28706426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of prokinetic agents used in the treatment of gastroparesis.
    Roe NA; Sakaan S; Swanson H; Twilla JD
    J Drug Assess; 2017; 6(1):6-9. PubMed ID: 28265483
    [No Abstract]   [Full Text] [Related]  

  • 37. The Burdens, Concerns, and Quality of Life of Patients with Gastroparesis.
    Yu D; Ramsey FV; Norton WF; Norton N; Schneck S; Gaetano T; Parkman HP
    Dig Dis Sci; 2017 Apr; 62(4):879-893. PubMed ID: 28110376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroparesis: Quality of Life and Health Care Utilization.
    Lacy BE; Crowell MD; Mathis C; Bauer D; Heinberg LJ
    J Clin Gastroenterol; 2018 Jan; 52(1):20-24. PubMed ID: 27775961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and oxidative stress-A concise review.
    Asmat U; Abad K; Ismail K
    Saudi Pharm J; 2016 Sep; 24(5):547-553. PubMed ID: 27752226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging strategies for the treatment of gastroparesis.
    Langworthy J; Parkman HP; Schey R
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):817-25. PubMed ID: 26840446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.